Moderna gets FDA fast track status for mRNA vaccine against novel coronavirus

This article was originally published here

Earlier this month, the FDA has completed its review of Moderna’s investigational new drug (IND) application for mRNA-1273 to conduct Phase 2 study, which is expected to be

The post Moderna gets FDA fast track status for mRNA vaccine against novel coronavirus appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply